Chelsea’s 25‑year‑old winger Mykhailo Mudryk now battles a four‑year doping ban that began in January after a routine urine test flagged the cardiovascular drug meldonium. The Football Association kept the decision confidential, revealing only the month the ban was issued.

The ban emerged from the FA’s anti‑doping programme, which operates behind closed doors to protect players’ privacy. Mudryk, who joined Chelsea for a record £61m in 2022, has been suspended from playing for both club and country since November 2024 and remains under contract until 2031.

Mudryk has lodged an appeal with the Court of Arbitration for Sport. If the ban is upheld, he would miss the next four years of football, potentially ending his Chelsea career. A reduced ruling could see him return next season, but the club could also terminate his contract, wiping the amortised transfer cost from its accounts.

Chelsea’s financial books would benefit from a contract termination, while the club’s squad depth would shrink further. The outcome will shape both the club’s wage structure and its competitive prospects for the remainder of the season.